Labcorp LH
Labcorp is a US-based clinical diagnostics and laboratory services company, offering lab tests, clinical trials, and research services to patients, hospitals, and pharmaceutical companies. Labcorp shows earnings growth of 28.20% and a forward P/E of 15.60, suggesting a reasonable valuation for its expansion pace, although its financial health (ND/EBITDA of 2.88) and operating margin of 12.24% are only moderate.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Labcorp is a US-based clinical diagnostics and laboratory services company, offering lab tests, clinical trials, and research services to patients, hospitals, and pharmaceutical companies. Labcorp shows earnings growth of 28.20% and a forward P/E of 15.60, suggesting a reasonable valuation for its expansion pace, although its financial health (ND/EBITDA of 2.88) and operating margin of 12.24% are only moderate.
Score by category
| Category | Score |
|---|---|
| Financial health | 5.6 |
| Quality / Moat | 5.0 |
| Valuation | 5.3 |
| Growth | 7.0 |
| Dividend | 4.9 |
| Momentum | 6.3 |
| Risk & Context | 7.1 |
OVERALL SCORE: 5.8/10
Context and risks
Labcorp's diagnostics and clinical laboratory business has no direct exposure to crude oil prices, Middle East tensions, or tariffs. The impact of interest rates is limited: with a Net Debt/EBITDA of 2.88, the effect of a higher rate environment is moderate and already reflected in the quantitative scores.
News considered in the analysis
- Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day — Señala intención de crecimiento inorgánico e inversión en tecnología, pero sin detalles concretos ni impacto financiero cuantificable.
- 2 Small-Cap Stocks to Research Further and 1 Facing Challenges — Listículo genérico sin información específica sobre Labcorp.
- Is Labcorp Holdings Stock Outperforming the Dow? — Comparativa de rendimiento bursátil sin información fundamental nueva.
- Stock Market Today: Dow Skids But Apple Eyes A Buy Point; Filing Says Trump Makes These Trades — Resumen de mercado sin relevancia específica para Labcorp.
- Why Labcorp Holdings Stock Dropped Today — Caída puntual de la acción, probablemente ligada a la rotación del mercado hacia sectores defensivos; sin noticia fundamental negativa específica.
Verdict: Hold; the company has solid growth and a reasonable valuation, but moderate debt and a higher interest rate environment limit near-term appeal.
Main risk: The main risk is the execution of its acquisition and technology investment strategy, which could increase leverage (ND/EBITDA already at 2.88) and fail to generate expected returns.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →